| Literature DB >> 30506332 |
Daniele Roberto Giacobbe1,2, Alessio Signori3, Mario Tumbarello4, Riccardo Ungaro5,6, Giovanni Sarteschi5,6, Elisa Furfaro6, Malgorzata Mikulska5,6, Maurizio Sanguinetti7, Brunella Posteraro8, Angela Raffaella Losito4, Gennaro De Pascale9, Valerio Del Bono6,10, Claudio Viscoli5,6.
Abstract
Desirability of outcome ranking (DOOR) has been developed for assessing desirability of outcome in interventional studies. However, its possible use in observational studies of the diagnosis and early treatment of infectious diseases has not been explored so far, and it might introduce interesting features in specific scenarios. This was a post hoc analysis of a prospective observational study in intensive care unit patients with sepsis and at risk of candidemia. The probabilities that a randomly selected patient would have a more, less, and equally cost-effective early therapeutic choice following a BDG-based diagnostic strategy rather than the empirical administration of antifungals to all patients were calculated using DOOR methods. The probability of a more cost-effective therapeutic choice following the BDG-based rather than the empirical strategy was 67.81% (95% CI 67.32-68.30), whereas the probabilities of a less and equally cost-effective early therapeutic choice were 19.68% (95% CI 19.27-20.10) and 12.50% (95% CI 12.16-12.85), respectively. The application of DOOR methods to observational studies focused on diagnosis and early treatment is a novel field that could merit further investigation.Entities:
Keywords: Biomarker; Candidemia; DOOR; Diagnosis; Glucan
Mesh:
Substances:
Year: 2018 PMID: 30506332 DOI: 10.1007/s10096-018-3441-1
Source DB: PubMed Journal: Eur J Clin Microbiol Infect Dis ISSN: 0934-9723 Impact factor: 3.267